Cartesian Therapeutics (RNAC) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cartesian Therapeutics Director Timothy Springer Buys $965k in Stock
InvestingDec 23 17:24 ET
BTIG Initiates Cartesian Therapeutics(RNAC.US) With Buy Rating, Announces Target Price $42
Moomoo NewsDec 20 13:43 ET · Ratings
Cartesian Therapeutics Price Target Announced at $42.00/Share by BTIG
Dow JonesDec 19 12:56 ET · Ratings
Cartesian Therapeutics Analyst Ratings
BenzingaDec 19 12:45 ET · Ratings
Revenues Not Telling The Story For Cartesian Therapeutics, Inc. (NASDAQ:RNAC)
Simply Wall StDec 18 08:04 ET
Cartesian Therapeutics Announces New Employment Inducement Grants
GlobeNewswireDec 18 07:05 ET

Comments

Jaguar8

Sep 9 06:32

NEWS

$Cartesian Therapeutics (RNAC.US)$
Cartesian Therapeutics Gets FDA Rare Pediatric Disease Designation for Dermatomyositis Treatment

Trytosaveabit

Jul 2 05:31

News

$Cartesian Therapeutics (RNAC.US)$ Press Release: Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing
Dow Jones· just

2

Trytosaveabit

Apr 10 15:53

Update! With 2 new 13D

$Cartesian Therapeutics (RNAC.US)$Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Murat Kalayoglu(19.9%),Seven One Eight Three Four Irrevocable Trust(17.1%), etc.
SEC announcement
13 mins ago
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals...

1

7

God(S) is Stonk

Mar 27 13:59

RNAC 👀

$Cartesian Therapeutics (RNAC.US)$ did no one notice springer just bought another 1.9million shares just today 👀, simply does not explain the price action point for this week at all. Eccentric !

God(S) is Stonk

Mar 26 11:19

$Cartesian Therapeutics (RNAC.US)$ FMR had a top position in Viking Therapeutics, and here in Cartesian as well. The reverse split is to allow more institutions to follow suit. If you were to read the paper closely on the pipeline, their RNA cell therapy extends to a suite of autoimmune diseases. With a production up and coming, more partnership might be announced very soon.

RNAC Cartesian Therapeutics

Trade Overview

Capital Trend

News

Comments